Clinical NewsCorrectionOct 4, 2004 In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.Latest in Clinical NewsSirtex Medical gains additional U.S. FDA clearance for SIR-Spheres Y-90July 7, 2025SPECT/CT identifies prostate cancer patients with poor outcomesJuly 7, 2025Penn Medicine to launch a mobile mammography programJuly 7, 2025SimonMed Imaging launches two new AI-enhanced mammogram servicesJuly 7, 2025Related StoriesBreastWhen push comes to shove: Addressing compression in mammographyBreastPreparation key to surviving MQSA inspectionsClinical NewsBiochem enters ultrasound domain in fetal screeningBreastBreast Imaging: The Requisites